| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/31/2002 | WO2002008291A2 Multi-specific reagent for selective stimulation of cell surface receptors |
| 01/31/2002 | WO2002008290A1 Dog melanin-concentrating hormone receptor |
| 01/31/2002 | WO2002008289A2 Novel proteins and nucleic acids encoding same |
| 01/31/2002 | WO2002008288A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/31/2002 | WO2002008287A2 Nk cells activating receptors and their therapeutic and diagnostic uses |
| 01/31/2002 | WO2002008286A2 Zinc finger domain recognition code and uses thereof |
| 01/31/2002 | WO2002008285A2 Il-17 molecules and uses thereof |
| 01/31/2002 | WO2002008284A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/31/2002 | WO2002008283A2 Lp120 polypeptides and therapeutic uses thereof |
| 01/31/2002 | WO2002008281A2 Bstp-cad protein and related reagents and methods of use thereof |
| 01/31/2002 | WO2002008279A2 B7-h2 molecules, novel members of the b7 family and uses thereof |
| 01/31/2002 | WO2002008278A2 Compositions and methods relating to lung specific genes |
| 01/31/2002 | WO2002008277A2 Nucleic acids, vectors, host cells, polypeptides, and uses thereof |
| 01/31/2002 | WO2002008275A2 Genes expressed in obese rat hypothalamus |
| 01/31/2002 | WO2002008274A2 56939, a human acyl-coa thioesterase family member and uses thereof |
| 01/31/2002 | WO2002008273A2 47508, a novel human histone deacetylase family member and uses thereof |
| 01/31/2002 | WO2002008272A2 High affinity soluble interleukin-18 receptor |
| 01/31/2002 | WO2002008271A1 Novel fibroblast growth factor (fgf23) and methods for use |
| 01/31/2002 | WO2002008270A2 A mort-1 interacting protein, its preparation and use |
| 01/31/2002 | WO2002008269A2 A cytochrome p450 enzyme associated with the synthesis of δ12-epoxy groups in fatty acids of plants |
| 01/31/2002 | WO2002008268A2 Leucine-based motif and clostridial neurotoxins |
| 01/31/2002 | WO2002008267A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/31/2002 | WO2002008266A2 Complete nucleotide sequence of staphylococcus aureus ribosomal protein s16 gene and methods for the identification of antibacterial substances |
| 01/31/2002 | WO2002008265A2 Staphylococcus aureus ribosomal protein s20, corresponding gene and methods for the identification of antibacterial substances |
| 01/31/2002 | WO2002008264A2 Papillomavirus infected epithelial cells and methods of producing infectious papillomavirus in epithelial cells and uses thereof |
| 01/31/2002 | WO2002008263A2 Modified virus having an altered tropism |
| 01/31/2002 | WO2002008259A2 Human cytokine receptor |
| 01/31/2002 | WO2002008257A2 Siglec (sialic acid-binding ig-related lectin) polypeptides and uses thereof |
| 01/31/2002 | WO2002008255A2 Cell cycle proteins and mitosis-associated molecules |
| 01/31/2002 | WO2002008253A2 A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY |
| 01/31/2002 | WO2002008252A2 Novel protein containing ring finger domaine r1p4 |
| 01/31/2002 | WO2002008245A2 Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation |
| 01/31/2002 | WO2002008242A1 Nucleic acids comprising regions of the rat peg-3 promoter and uses thereof |
| 01/31/2002 | WO2002007776A1 The protein kinase domain of the large subunit of herpes simplex type 2 ribonucleotide reductase (icp10pk) has anti-apoptopic activity |
| 01/31/2002 | WO2002007773A2 Multi-component biological transport systems |
| 01/31/2002 | WO2002007763A2 Helicobacter pylori with modified lipopolysaccharide biosynthesis |
| 01/31/2002 | WO2002007754A2 New use |
| 01/31/2002 | WO2002007752A2 Red blood cell as vehicle for agent-membrane translocation sequence conjugate |
| 01/31/2002 | WO2002007678A2 Mu-conopeptides |
| 01/31/2002 | WO2002007675A2 Omega-conopeptides |
| 01/31/2002 | WO2002007646A2 Artificial vascular grafts, and methods of producing and using same |
| 01/31/2002 | WO2002007529A2 Methods for high-temperature hydrolysis of galactose-containing oligosaccharides in complex mixtures |
| 01/31/2002 | WO2002007514A2 Glycosylated vegf-b and method for increasing the amount of soluble vegf-b |
| 01/31/2002 | WO2002007504A2 Hybrid soybeans and methods of production |
| 01/31/2002 | WO2001083562A3 Hybrid protein and vector encoding the same for inhibition of angiogenesis |
| 01/31/2002 | WO2001080873A3 Thrombopoietin receptor modulating peptide |
| 01/31/2002 | WO2001079485A3 Direct isolation of transposon insertions tagging transcribed portions of genes |
| 01/31/2002 | WO2001079461A3 Polypeptides having haloperoxidase activity |
| 01/31/2002 | WO2001077321A3 Identification of a human gaba transporter |
| 01/31/2002 | WO2001072974A3 L-galactose dehydrogenase from arabidopsis thaliana, and uses thereof |
| 01/31/2002 | WO2001071015A3 Non-squamous epithelium-specific transcription |
| 01/31/2002 | WO2001070993A3 Polynucleotides that control delta-6-desaturase genes and methods for identifying compounds for modulating delta-6-desaturase |
| 01/31/2002 | WO2001068868A3 Alpha(iii) subunit of prolyl 4-hydroxylase |
| 01/31/2002 | WO2001068146A3 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene |
| 01/31/2002 | WO2001068120A3 Uses of bombesin receptor 3 |
| 01/31/2002 | WO2001064871A3 MAMMALIAN PRO-α3(V) COLLAGEN CHAIN GENES |
| 01/31/2002 | WO2001064870A3 Mutated cyclin g1 protein |
| 01/31/2002 | WO2001063284A9 Internal standards and controls for multiplexed assay |
| 01/31/2002 | WO2001062940A3 New phosphodiesterase type 7b |
| 01/31/2002 | WO2001062801A3 Humanized antibodies that sequester amyloid beta peptide |
| 01/31/2002 | WO2001062784A3 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 01/31/2002 | WO2001061017A3 Modified cytokines for use in cancer therapy |
| 01/31/2002 | WO2001057075A3 Virulence genes, proteins, and their use |
| 01/31/2002 | WO2001057065A3 Combinatorial protein domains |
| 01/31/2002 | WO2001054472A3 Nucleic acids, proteins, and antibodies |
| 01/31/2002 | WO2001053479A3 Molecular switches ii |
| 01/31/2002 | WO2001053476A3 Novel plant promoters and methods of use |
| 01/31/2002 | WO2001051654A3 Methods and kits for identifying elite event gat-zm1 in biological samples |
| 01/31/2002 | WO2001051622A3 P450 monooxygenases of the cyp79 family |
| 01/31/2002 | WO2001049883A3 Amplification based polymorphism detection |
| 01/31/2002 | WO2001048485A3 Selecting library members capable of binding to epitopes |
| 01/31/2002 | WO2001044811A3 Plasminogen activator assay involving an elastase inhibitor |
| 01/31/2002 | WO2001044482A3 Optimized t-dna transfer and vectors therefor |
| 01/31/2002 | WO2001044478A3 CORE 1 β3-GALACTOSYL TRANSFERASES AND METHODS OF USE THEREOF |
| 01/31/2002 | WO2001042457A3 Uncharged antisense oligonucleotides targeted to bacterial 16s and 23s prnas and their uses |
| 01/31/2002 | WO2001040473A3 Pseudomonas aeruginosa antigens |
| 01/31/2002 | WO2001038550A3 Methods for altering the expression of hyphal-specific genes |
| 01/31/2002 | WO2001038514A3 Methods, media and apparatus for the introduction of molecules into plant cells and bacteria using aerosol beams |
| 01/31/2002 | WO2001038508A3 Method for carrying out the controlled post-harvest production of proteins in host organisms |
| 01/31/2002 | WO2001038503A3 Novel human protein kinases and protein kinase-like enzymes |
| 01/31/2002 | WO2001036605A3 2786, a human aminopeptidase |
| 01/31/2002 | WO2001034801A3 Recombinant gelatin in vaccines |
| 01/31/2002 | WO2001031343A3 Diagnosis and therapy of cancer using sgp28-related molecules |
| 01/31/2002 | WO2001029085A3 Cdt6 can inhibit angiogenesis and tumor growth, and can induce or enhance the formation of structures containing collagen v |
| 01/31/2002 | WO2001024624A3 Method for reconstructing a non-human mammal embryo with foetal adult differentiated cells |
| 01/31/2002 | WO2001023596A3 Production of polyhydroxyalkanoate in plants |
| 01/31/2002 | WO2001013958A3 Drug conjugates and methods of designing the same |
| 01/31/2002 | WO2001012859A3 Detection of differences in nucleic acids by inhibition of spontaneous dna branch migration |
| 01/31/2002 | WO2001008634A3 Polynucleotide encoding a human serine protease |
| 01/31/2002 | WO2000072869A9 Methods for producing 5'-nucleic acid-protein conjugates |
| 01/31/2002 | WO2000068434A3 Multiple tag analysis |
| 01/31/2002 | WO2000063410A9 Methods and compositions for transforming cells using site-specific recombination |
| 01/31/2002 | WO2000060919B1 Anchored strand displacement amplification on an electronically addressable microchip |
| 01/31/2002 | WO2000060124A3 Fixed address analysis of sequence tags |
| 01/31/2002 | WO2000060114A3 Polynucleotide sequencing using a helicase |
| 01/31/2002 | WO2000057910A9 Attenuated dengue-4 virus vaccine |
| 01/31/2002 | WO2000056900A3 Promoter sequences derived from fusarium venenatum and uses thereof |
| 01/31/2002 | WO2000049173A3 Method and sample support system for separating and processing substances in situ |
| 01/31/2002 | US20020013960 Corn event PV-ZMGT32(nk603) and compositions and methods for detection thereof |
| 01/31/2002 | US20020013958 Polynucleotides and polypeptides derived from corn seedling |